Scarica l'app Stockscreener
0.00
100.00%
-15.68
Precedente Chiudi:
$15.68
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$9.35M
Reddito:
$9.81M
Utile/perdita netta:
$-26.16M
Rapporto P/E:
0.00
EPS:
-38.77
Flusso di cassa netto:
$-17.45M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$519.00
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Nome
Reshape Lifesciences Inc
Settore
Industria
Telefono
949-429-6680
Indirizzo
1001 CALLE AMANECER, SAN CLEMENTE
Confronta RSLS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
0.00 | 9.35M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.86 | 223.39B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.95 | 136.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.69 | 135.88B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.72 | 126.37B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.32 | 48.39B | 5.88B | 1.34B | 799.60M | 2.3489 |
Reshape Lifesciences Inc Borsa (RSLS) Ultime notizie
Global Medical Tourism Market to Reach USD 58 Billion by 2032, Due to Shift Toward Affordable, Quality Healthcare Abroad | DelveInsight - Business Upturn
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
HIND Stock Price and Chart — NASDAQ:HIND - TradingView
Is ReShape Lifesciences Inc. stock a smart buy before Fed meetingEarnings Miss & Safe Swing Trade Setups - Newser
Will ReShape Lifesciences Inc. stock recover faster than peersBear Alert & Community Trade Idea Sharing - Newser
Is ReShape Lifesciences Inc. stock dividend yield sustainableWeekly Investment Summary & AI Optimized Trading Strategy Guides - Newser
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Vyome Holdings Inc. Reports Post-Merger Financials - MSN
Why ReShape Lifesciences Inc. stock is rated strong buyDay Trade & Smart Allocation Stock Tips - newser.com
Will ReShape Lifesciences Inc. stock maintain dividend yieldJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
How ReShape Lifesciences Inc. stock performs in rising dollar environmentMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Live market analysis of ReShape Lifesciences Inc.July 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Tools to monitor ReShape Lifesciences Inc. recovery probability2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Comparing ReShape Lifesciences Inc. in custom built stock radarsTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
Is now a turning point for ReShape Lifesciences Inc.Profit Target & Stepwise Entry/Exit Trade Alerts - newser.com
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism - MSN
Will ReShape Lifesciences Inc. stock benefit from green energy trendsTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Why ReShape Lifesciences Inc. stock is a must watch in 2025July 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Is ReShape Lifesciences Inc. stock safe for conservative investorsPortfolio Return Summary & Weekly Momentum Picks - newser.com
Head-To-Head Analysis: ReShape Lifesciences (OTCMKTS:RSLSD) versus Bioventus (NASDAQ:BVS) - Defense World
United States Weight Loss Devices Market 2025: Top - openPR.com
Will earnings trigger a reversal in ReShape Lifesciences Inc.2025 Growth vs Value & Long-Term Growth Plans - newser.com
Reshape Lifesciences Inc Azioni (RSLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):